BioCentury
ARTICLE | Financial News

Quintiles IMS: Drug price increases to slow

December 8, 2016 12:03 AM UTC

In a new report describing its outlook for pharmaceutical spending, Quintiles IMS Holdings Inc. (NYSE:Q) said it expects both list and net prices of U.S. drugs to grow more slowly in the next five years than in recent years. It predicted an 8-11% annual increase in invoice prices for branded pharmaceuticals in the U.S. through 2021, down from 12-13% from 2011-14. It estimated annual net price increases of 2-5%, compared with increases of 4.9-9.1% from 2011-14...

BCIQ Company Profiles

IQVia Holdings Inc.